Evommune EVMN
NYSE EVMN
$8.31 -0.08 (-0.95%)
As of: Sep 29, 2026 · 3:59 PM EDT

Evommune (EVMN) Total Liabilities (2024 - 2026)

Updated

Evommune (EVMN) posted Total Liabilities of $24.36 million for Q2 2026, up 36.1% from the prior quarter.

Analysis

Evommune (EVMN) Total Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Evommune's Total Liabilities came in at $19.38 million, down 91.2% from FY2024.

  • In prior years, Evommune's Total Liabilities was $220.29 million in FY2024.
  • Quarterly Total Liabilities has run from a low of $17.9 million in Q1 2026 to a high of $267.68 million in Q3 2025 over five years.
  • According to Business Quant data, Total Liabilities for the three prior quarters was $17.9 million (Q1 2026), $19.38 million (Q4 2025) and $267.68 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Evommune 304.40 Mn -333.11 Mn - 24.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.36 Mn
Mar 31, 2026 17.90 Mn
Dec 31, 2025 19.38 Mn
Sep 30, 2025 267.68 Mn
Dec 31, 2024 220.29 Mn
API Access

Evommune Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=EVMN&period=max&api_key=YOUR_API_KEY